Anika Therapeutics (ANIK) Long-Term Deferred Tax (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Long-Term Deferred Tax of $1.0 million for Q2 2026, down 18.9% year-over-year from $1.3 million in Q2 2025, and down 11.57% quarter-over-quarter from $1.2 million in Q1 2026.
Anika Therapeutics (ANIK) Long-Term Deferred Tax (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Long-Term Deferred Tax for 10 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Long-Term Deferred Tax fell 18.9% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $1.0 million (down 18.9% YoY), while the FY2025 annual figure was $1.3 million, up 8.33% from the prior year.
- Long-Term Deferred Tax slipped to $1.0 million in Q2 2026 per ANIK's latest filing, from $1.2 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $1.5 million in Q1 2023 and bottomed at $1.0 million in Q2 2026.
- Historically, Long-Term Deferred Tax has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax slipped 20.95% — and 2025, when it climbed 8.33%.
- Anika Therapeutics' Long-Term Deferred Tax stood at $1.4 million in 2022, then climbed by 2.76% to $1.5 million in 2023, then dropped by 20.95% to $1.2 million in 2024, then climbed by 8.33% to $1.3 million in 2025, then dropped by 20.24% to $1.0 million in 2026.
- Business Quant data shows ANIK's Long-Term Deferred Tax at $1.0 million in Q2 2026, $1.2 million in Q1 2026, and $1.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Anika Therapeutics | 286.14 Mn | 247.73 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 1.25 Mn |
| Jun 30, 2025 | 1.25 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Dec 31, 2019 | 11.53 Mn |
| Dec 31, 2018 | 7.21 Mn |
| Dec 31, 2013 | 5.74 Mn |
| Dec 31, 2012 | 7.65 Mn |
| Dec 31, 2010 | 392,005.00 |